TRB Wealth Management LLC purchased a new stake in shares of CME Group Inc. (NASDAQ:CME – Free Report) in the second quarter, HoldingsChannel reports. The firm purchased 2,186 shares of the financial services provider’s stock, valued at approximately $483,000.
Other institutional investors and hedge funds have also made changes to their positions in the company. Whipplewood Advisors LLC lifted its holdings in shares of CME Group by 2,075.0% in the 1st quarter. Whipplewood Advisors LLC now owns 87 shares of the financial services provider’s stock worth $26,000 after acquiring an additional 83 shares during the last quarter. Elkhorn Partners Limited Partnership acquired a new stake in CME Group in the 4th quarter valued at approximately $27,000. Hilton Head Capital Partners LLC purchased a new stake in CME Group in the fourth quarter valued at approximately $28,000. Mowery & Schoenfeld Wealth Management LLC purchased a new stake in CME Group in the second quarter valued at approximately $28,000. Finally, Legacy Wealth Managment LLC ID lifted its stake in CME Group by 191.9% during the fourth quarter. Legacy Wealth Managment LLC ID now owns 108 shares of the financial services provider’s stock worth $29,000 after purchasing an additional 71 shares in the last quarter. 87.75% of the stock is owned by hedge funds and other institutional investors.
CME Group Price Performance
CME Group stock opened at $274.98 on Friday. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13. CME Group Inc. has a 52-week low of $218.31 and a 52-week high of $329.16. The firm has a market cap of $98.88 billion, a PE ratio of 23.32, a price-to-earnings-growth ratio of 3.16 and a beta of 0.23. The company’s 50 day moving average is $251.17 and its two-hundred day moving average is $279.65.
CME Group Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Friday, September 25th. Investors of record on Wednesday, September 9th will be issued a $1.30 dividend. The ex-dividend date is Wednesday, September 9th. This represents a $5.20 dividend on an annualized basis and a yield of 1.9%. CME Group’s dividend payout ratio (DPR) is 44.11%.
Analyst Upgrades and Downgrades
CME has been the subject of several research analyst reports. Raymond James Financial restated an “outperform” rating and set a $320.00 price target on shares of CME Group in a research report on Thursday, July 2nd. Deutsche Bank Aktiengesellschaft downgraded CME Group from a “buy” rating to a “hold” rating and cut their price objective for the company from $286.00 to $270.00 in a report on Wednesday. Bank of America increased their target price on CME Group from $226.00 to $230.00 and gave the stock an “underperform” rating in a research note on Thursday, July 23rd. Rothschild & Co Redburn upgraded CME Group from a “neutral” rating to a “buy” rating and raised their target price for the company from $316.00 to $323.00 in a report on Thursday, June 11th. Finally, Barclays dropped their target price on CME Group from $316.00 to $270.00 and set an “equal weight” rating for the company in a research report on Thursday, July 9th. Nine investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have assigned a Sell rating to the company’s stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $288.56.
View Our Latest Stock Analysis on CME Group
Insider Buying and Selling
In related news, Director William R. Shepard bought 325 shares of the stock in a transaction that occurred on Thursday, June 25th. The stock was purchased at an average cost of $230.57 per share, with a total value of $74,935.25. Following the purchase, the director directly owned 260,442 shares of the company’s stock, valued at $60,050,111.94. This trade represents a 0.12% increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through this link. 0.30% of the stock is owned by insiders.
CME Group Profile
CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.
The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.
Featured Stories
- Five stocks we like better than CME Group
- Blueprint for a Boom: SEC Clears the Crypto Runway
- Ross Stores Just Flipped the Off-Price Retail Story After TJX’s Marmaxx Miss
- Advance Auto Parts Plunged, But Its Turnaround Is Still Working
- Is Palo Alto Networks Priced for Perfection Again as AI Security Demand Accelerates?
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Free Report).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.
